Primary Hyperaldosteronism

Article Author:
Alexander Cobb

Article Editor:
Narothama Aeddula

Editors In Chief:
Stephen Leslie
Karim Hamawy

Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi

4/21/2019 9:08:43 AM


Primary hyperaldosteronism (PA) is an under-diagnosed cause of hypertension. The presentation is classically known to occur as a patient with hypertension and hypokalemia. However, in reality, most patients will present without hyperkalemia. The two primary causes are aldosterone-producing adenomas and bilateral adrenal hyperplasia of the zona glomerulosa. Some familial causes have been found and are classified into Type I, Type II, and Type III familial hyperaldosteronism. Diagnosis can initially be confirmed with the elevated morning aldosterone to plasma renin activity ratio. If the ratio is higher than 20 to 1; then the excess aldosterone points to the adrenal gland as the primary source. The preferred treatment is adrenalectomy in those with unilateral disease. Those who are poor surgical candidates or have bilateral adrenal hyperplasia can be treated medically with mineralocorticoid antagonists as well as antihypertensive agents for further blood pressure control.


The most prevalent cause of primary hyperaldosteronism is aldosterone-producing adenomas. Other causes include aldosterone-producing adrenal carcinoma, ectopic aldosterone secretion from the kidneys or ovaries, and bilateral zona glomerulosa hyperplasia. There are familial causes as well. Type I is glucocorticoid-remediable hyperaldosteronism that results from the formation of a chimeric gene containing the regulator portion of 11B-hydroxylase (usually regulated by ACTH) and the synthetic region of aldosterone synthase; as a result, ACTH stimulates aldosterone synthase and hence aldosterone production. Type II causes are unclear; it correlates to a gene on 7p22 (band 11q13), and histologic findings are consistent with hyperplasia or adenomas.[1] Type III results from a mutation in KCNJF which is a potassium channel coding gene. This mutation causes increased calcium ion availability into the glomerulosa cells leading to increased aldosterone synthesis.[2][3]


Primary hyperaldosteronism occurs worldwide, and no evidence suggests that there are more cases of primary hyperaldosteronism in certain areas of the world. Aldosterone-producing adenomas occur more frequently in women than in men. Reports are that there may be a higher prevalence in African Americans or persons from African origin; this is demonstrated more in the idiopathic adrenal hyperplasia variant of the disease.[4][5]

History and Physical

A patient with suspected primary hyperaldosteronism will present with uncontrolled hypertension and will typically be young. These patients will require up to three antihypertensive medications including a diuretic to maintain suboptimal blood pressure control. They can also have a family history of early-onset hypertension or cerebral vascular disease at a younger age. Patients may have severe muscle weakness, palpitations, fatigue, or muscle cramps due to symptoms related to hypokalemia. Polydipsia and polyuria are present due to nephrogenic diabetes insipidus likely secondary to hypokalemia. 

Hypokalemia has been considered one of the hallmark signs in the diagnosis of primary aldosteronism; however, estimates are now that less than 37 percent of patients who have primary hyperaldosteronism will present with hypokalemia.[5] Patients who have adequate sodium intake will often be more hypokalemic. Increasing sodium intake will allow more sodium delivery to the cortical collecting tubules promoting further excretion of potassium in the setting of excess aldosterone.[5] Even though patients typically do not present with hypokalemia; the diagnosis should be considered in a patient with drug-resistant hypertension and hypokalemia in a patient starting a low dose of diuretic.

There are no physical exam characteristics that will lead to a diagnosis of primary hyperaldosteronism. However, due to excessive hypertension and stress on the heart, left ventricular hypertrophy can occur leading to an S4 heart sound secondary to blood trying to enter a noncompliant stiff ventricle during atrial contraction. Other findings related to longstanding hypertension can arise throughout the body affecting the heart (heart failure), kidneys (proteinuria), eyes (hypertensive retinal changes), vasculature (carotid bruits/stroke symptoms), muscle weakness, and mental status changes secondary to hypertensive encephalopathy. 


The Endocrine Society recommends screening for specific patient presentations. Patients with hypertension on triple-drug therapy and diuretic-induced hypokalemia; patients with hypertension and adrenal incidentaloma; hypertension with a family history of the early-onset cerebral vascular accident; or patients with hypertension and first-degree relatives with confirmed primary hyperaldosteronism.[6]

Suspect primary aldosteronism when a patient presents with hypertension at an early age with hypokalemia and poorly controlled blood pressure despite medical therapy. The next step is to obtain a morning plasma aldosterone and renin activity. If the ratio of morning aldosterone to plasma renin activity is higher than 20 to 1; then the excess aldosterone can be attributed to the adrenal gland as the primary source. Next, any of the four confirmatory tests may follow: 1) oral sodium loading 2) saline infusion 3) fludrocortisone suppression 4) captopril challenge, should suppress aldosterone; however, in a patient with primary aldosteronism, there will be a lack of aldosterone suppression. Once primary aldosteronism is confirmed all suspected patients are recommended to undergo Adrenal computed tomography scan as the initial study and to exclude possible adrenocortical carcinoma. It is then recommended for the patient to have an adrenal venous sampling.[7]

The best diagnostic test involves the measurement of cortisol and aldosterone in bilateral adrenal venous effluent and a peripheral vein before and during an ACTH infusion. Cortisol will be used to evaluate the catheter placement in the adrenal veins, as levels from the two sides should be similar. When an adenoma is present, the aldosterone-to-cortisol ratio on one side is usually at least five times greater than the other indicating suppression. Bilateral hyperplasia tends to produce similar values on each side. If the study points towards a unilateral adenoma, then laparoscopic adrenalectomy is the preferred treatment. If the patient declines surgery or is not a surgical candidate, medical therapy is the recommended route. If the study points towards a bilateral cause, then medical treatment with a mineralocorticoid antagonist is warranted.[8]

Treatment / Management

Treatment for primary hyperaldosteronism includes laparoscopic resection for adenomas. This procedure will usually resolve the hypokalemia, but hypertension can persist in up to 65% of patients post adrenalectomy. Surgery is the preferred treatment for patients with unilateral aldosterone-producing adenoma. After unilateral adrenalectomy, almost all patients have the resolution of hypokalemia and moderate improvement in blood pressure control.[9] In those who are unable to undergo surgery or have bilateral adrenal hyperplasia, mineralocorticoid antagonists such as spironolactone or eplerenone are an option. In a randomized study, the antihypertensive effects between spironolactone and eplerenone in patients with primary hyperaldosteronism were studied showing that spironolactone was more effective than eplerenone in controlling blood pressure.[10] Amiloride, a sodium channel blocker, may be helpful in the treatment and other antihypertensive agents can be continued as needed to optimize blood pressure control. Spironolactone is considered the first line agent for patients who cannot undergo surgical resection.  

Differential Diagnosis

In patients with refractory hypertension, some other differentials to include are renal artery stenosis, secondary aldosteronism, pheochromocytoma (spontaneous and drug-mediated),[11] deoxycorticosterone secreting tumors, renin-secreting tumor from the juxtaglomerular apparatus, and renovascular ischemia.[12] Excessive licorice intake can lead to the impairment of conversion of cortisol to cortisone in the kidneys; this is because the glycyrrhizinic acid portion of the licorice inhibits 11-beta-hydroxysteroid dehydrogenase. Excess cortisol will then bind to mineralocorticoid receptors acting as a mineralocorticoid.[13]

Other genetic diseases presenting similar to primary hyperaldosteronism include but are not limited to:

Chrétien syndrome is a rare syndrome that is caused by excess secretion of POMC from pituitary adenoma leading to adrenocortical hypertension.[14]

Gitelman syndrome, which is a loss of function of the sodium chloride cotransporter in the renal tubules, leading to salt wasting and secondary hyperaldosteronism.[15]

Liddle syndrome is a pseudohyperaldosteronism which is a rare autosomal dominant disorder causing hyperactive renal epithelial sodium channels with increased sodium reabsorption in the distal tubules. In this syndrome, levels of renin and aldosterone are low.[16]


Studies show that morbidity and mortality of those with primary hyperaldosteronism are directly related to chronic elevated hypertension leading to increased risk of cardiovascular disease including CAD, stroke, and congestive heart failure secondary to left ventricular hypertrophy.[17][18] Other studies point to the increased risk of cardiac arrhythmias secondary to persistent hypokalemia in those with primary hyperaldosteronism.[14] Research has shown in individual studies that surgical correction by adrenalectomy leads to a better prognosis by a significant reduction in hypertension and hypokalemia when compared to those with medical therapy.[19]


Cardiovascular risk is associated with patients who have primary aldosteronism because these patients will have greater mass measurements of the left ventricle as well as decreased left ventricular function when compared to patients with other types of hypertension.[20][21] Other cardiovascular risks include stroke, atrial fibrillation, and myocardial infarction. There was a prospective study done comparing 54 patients with primary hyperaldosteronism who had treatment with either spironolactone, a mineralocorticoid receptor antagonist, or surgical resection of an adrenal adenoma. The control group was patients with primary hypertension matched for age, gender, BMI, and duration of hypertension. The study found that before treatment, patients with primary hyperaldosteronism had a greater prevalence of cardiovascular events than those with primary hypertension. After treatment of the mineralocorticoid excess whether it be by surgical resection of adenomas or by spironolactone; there was no longer an elevated cardiovascular risk for those with primary hyperaldosteronism. The patients received follow-up for roughly seven years, and there was no significant difference between each group when it came to reaching the primary outcome of myocardial infarction, revascularization procedure, sustained arrhythmia, or stroke.[22]

Metabolic syndrome is more common in those with primary hyperaldosteronism as compared to controls with similar blood pressure, sex, age, and BMI.[23]

Increased aldosterone blood levels lead to increasing GFR and renal perfusion pressure. These patients will also have increased urinary albumin excretion. A study of a series of 50 patients with primary aldosteronism treated with either adrenalectomy or spironolactone was compared to those with primary hypertension on antihypertensive therapy. The results showed that at baseline, patients with primary aldosteronism had higher GFRs and albumin excretion than patients with primary hypertension. However, after a six-month follow-up of the treated primary aldosteronism patients, it was found that albuminuria was significantly decreased in addition to the reduction in the GFR when compared to the primary hypertension group.[24] This research shows that with surgical resection or medical therapy in those with primary hyperaldosteronism, an underlying renal insufficiency could be present due to reversing the hyperfiltration state.  

Prior stroke was found to be significantly higher in patients with primary hyperaldosteronism (12.9%) than those with primary hypertension (3.4%) in a retrospective study comparing a total of 124 patients with primary hyperaldosteronism and 465 patients with primary hypertension. The two groups had similar ages, genders, and mean blood pressure of 175/107.[25]




General surgery

Interventional radiology

Deterrence and Patient Education

Patients should be educated with the common symptoms of primary hyperaldosteronism and be aware of the common family history findings to report to their physicians. Patients should be mindful of bringing up any early family history of hypertension or stroke in an immediate family member. When diagnosed with hyperaldosteronism, patients should understand the importance of compliance with medical therapy as this is the only treatment besides surgical intervention. Patients diagnosed with essential hypertension at a young age that have been refractory to treatment on multiple medications should mention to the primary care physicians of their compliance and provide a record of blood pressure readings as this will help their physician evaluate further causes of hypertension.  

Enhancing Healthcare Team Outcomes

In patients with suspected primary hyperaldosteronism, it is critical to maintain interprofessional communication between the primary care physician, endocrinologist, nurse practitioner, and the laboratory team. The workup of suspected primary hyperaldosteronism involves an initial blood test of aldosterone to plasma renin activity, and this needs to be drawn early in the morning, preferably before 8 am. Discussion between the healthcare provider and lab team should take place if working in the hospital, or conversation with the patient if working up outpatient. Confirmatory tests including oral sodium loading or saline infusion require timely blood draws by lab staff and careful instruction to the patient for sodium loading to allow for accurate results. Once diagnosed, especially if by an endocrinologist, it is important to thoroughly document the steps of the workup and goals of treatment as this will help the interprofessional communication with the primary care physician, nurse practitioner or surgeon if the patient is a surgical candidate for adrenalectomy. A thorough explanation of the treatment options should be given to the patient to allow them to be a part of the medical team.  

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Primary Hyperaldosteronism - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is not a feature of primary hyperaldosteronism?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
A 65-year-old woman presents with generalized weakness, polydipsia, and polyuria. Her blood pressure is 170/95 mm Hg, which is a new finding for this patient. Laboratories show normal BUN and creatinine, but there is hypernatremia and hypokalemia. A CT scan shows a left adrenal nodule. What is the likely etiology of her disorder?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
A woman has a blood pressure of 180/115 and a potassium of 2.8. Which of the following tests should be ordered?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
Which of the following lab findings is confirmatory of primary hyperaldosteronism?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
A patient on a normal sodium diet has primary hyperaldosteronism. Which of the following lab values would be expected?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up

Primary Hyperaldosteronism - References


Funder JW, The genetic basis of primary aldosteronism. Current hypertension reports. 2012 Apr;     [PubMed]
Choi M,Scholl UI,Yue P,Björklund P,Zhao B,Nelson-Williams C,Ji W,Cho Y,Patel A,Men CJ,Lolis E,Wisgerhof MV,Geller DS,Mane S,Hellman P,Westin G,Åkerström G,Wang W,Carling T,Lifton RP, K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (New York, N.Y.). 2011 Feb 11;     [PubMed]
Käyser SC,Deinum J,de Grauw WJ,Schalk BW,Bor HJ,Lenders JW,Schermer TR,Biermans MC, Prevalence of primary aldosteronism in primary care: a cross-sectional study. The British journal of general practice : the journal of the Royal College of General Practitioners. 2018 Feb;     [PubMed]
Mulatero P,Stowasser M,Loh KC,Fardella CE,Gordon RD,Mosso L,Gomez-Sanchez CE,Veglio F,Young WF Jr, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. The Journal of clinical endocrinology and metabolism. 2004 Mar;     [PubMed]
Williams TA,Reincke M, MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. European journal of endocrinology. 2018 Jul;     [PubMed]
Mattsson C,Young WF Jr, Primary aldosteronism: diagnostic and treatment strategies. Nature clinical practice. Nephrology. 2006 Apr;     [PubMed]
Rossi GP,Auchus RJ,Brown M,Lenders JW,Naruse M,Plouin PF,Satoh F,Young WF Jr, An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension (Dallas, Tex. : 1979). 2014 Jan;     [PubMed]
Milsom SR,Espiner EA,Nicholls MG,Gwynne J,Perry EG, The blood pressure response to unilateral adrenalectomy in primary aldosteronism. The Quarterly journal of medicine. 1986 Dec;     [PubMed]
Parthasarathy HK,Ménard J,White WB,Young WF Jr,Williams GH,Williams B,Ruilope LM,McInnes GT,Connell JM,MacDonald TM, A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. Journal of hypertension. 2011 May;     [PubMed]
Schiffrin EL,Chrétien M,Seidah NG,Lis M,Gutkowska J,Cantin M,Genest J, Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1983 Apr;     [PubMed]
Fujimura J,Nozu K,Yamamura T,Minamikawa S,Nakanishi K,Horinouchi T,Nagano C,Sakakibara N,Nakanishi K,Shima Y,Miyako K,Nozu Y,Morisada N,Nagase H,Ninchoji T,Kaito H,Iijima K, Clinical and Genetic Characteristics in Patients With Gitelman Syndrome. Kidney international reports. 2019 Jan;     [PubMed]
Fan P,Lu CX,Zhang D,Yang KQ,Lu PP,Zhang Y,Meng X,Hao SF,Luo F,Liu YX,Zhang HM,Song L,Cai J,Zhang X,Zhou XL, Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B. Endocrine connections. 2018 Nov 1;     [PubMed]
Sabbadin C,Armanini D, Syndromes that Mimic an Excess of Mineralocorticoids. High blood pressure     [PubMed]
Bernini G,Galetta F,Franzoni F,Bardini M,Taurino C,Bernardini M,Ghiadoni L,Bernini M,Santoro G,Salvetti A, Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. Journal of hypertension. 2008 Dec;     [PubMed]
Ohno Y,Sone M,Inagaki N,Yamasaki T,Ogawa O,Takeda Y,Kurihara I,Itoh H,Umakoshi H,Tsuiki M,Ichijo T,Katabami T,Tanaka Y,Wada N,Shibayama Y,Yoshimoto T,Ogawa Y,Kawashima J,Takahashi K,Fujita M,Watanabe M,Matsuda Y,Kobayashi H,Shibata H,Kamemura K,Otsuki M,Fujii Y,Yamamoto K,Ogo A,Okamura S,Miyauchi S,Fukuoka T,Izawa S,Yoneda T,Hashimoto S,Yanase T,Suzuki T,Kawamura T,Tabara Y,Matsuda F,Naruse M, Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Hypertension (Dallas, Tex. : 1979). 2018 Mar;     [PubMed]
Miyake Y,Tanaka K,Nishikawa T,Naruse M,Takayanagi R,Sasano H,Takeda Y,Shibata H,Sone M,Satoh F,Yamada M,Ueshiba H,Katabami T,Iwasaki Y,Tanaka H,Tanahashi Y,Suzuki S,Hasegawa T,Katsumata N,Tajima T,Yanase T, Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocrine journal. 2014;     [PubMed]
Yoshihara F,Nishikimi T,Yoshitomi Y,Nakasone I,Abe H,Matsuoka H,Omae T, Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. American journal of hypertension. 1996 Jun;     [PubMed]
Stowasser M,Sharman J,Leano R,Gordon RD,Ward G,Cowley D,Marwick TH, Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. The Journal of clinical endocrinology and metabolism. 2005 Sep;     [PubMed]
Catena C,Colussi G,Nadalini E,Chiuch A,Baroselli S,Lapenna R,Sechi LA, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Archives of internal medicine. 2008 Jan 14;     [PubMed]
Hanslik G,Wallaschofski H,Dietz A,Riester A,Reincke M,Allolio B,Lang K,Quack I,Rump LC,Willenberg HS,Beuschlein F,Quinkler M,Hannemann A, Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. European journal of endocrinology. 2015 Nov;     [PubMed]
Sechi LA,Novello M,Lapenna R,Baroselli S,Nadalini E,Colussi GL,Catena C, Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006 Jun 14;     [PubMed]
Milliez P,Girerd X,Plouin PF,Blacher J,Safar ME,Mourad JJ, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology. 2005 Apr 19;     [PubMed]
Dutta RK,Söderkvist P,Gimm O, Genetics of primary hyperaldosteronism. Endocrine-related cancer. 2016 Oct;     [PubMed]
Hosseinnezhad A,Black RM,Aeddula NR,Adhikari D,Trivedi N, Glucagon-induced pheochromocytoma crisis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2011 May-Jun     [PubMed]
Rimoldi SF,Scherrer U,Messerli FH, Secondary arterial hypertension: when, who, and how to screen? European heart journal. 2014 May 14     [PubMed]


The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.